Welcome to Key Biologics
Key Biologics' goal and our clients' goals are the same: To advance life science from discovery, through R&D and into curing disease. The organization provides unique and high-value human-derived biomaterials (cells and blood components) derived from human blood, umbilical cord, and in the near future, bone marrow. In that effort, Key Biologics supports the work of researchers worldwide at major universities in early-stage biotech companies and in large drug companies. Provision of these blood products makes possible first-in-human clinical trials of biological drugs that may one day cure blood disorders such as sickle cell disease and some forms of cancer and vaccines that may one day prevent malaria.
Individuals who make blood donations and participate in our research studies are compensated for their time and effort. Prior to scheduling a blood product collection, the specific compensation schedule is provided to the individual. Compensation varies based on the type of blood products collected along with the amount of time needed to perform the collection. Some studies require a participant to make several visits to Key Biologics while others require only a single visit. Visits can take from 45 minutes to 4 hours based on the study and the activity associated with the visit.
Key Biologics' customers are in the forefront of medical research. Our ability to provide blood products that meet their defined specifications allows them to continue the advancement of medical research. Blood products provided by our donors support the research behind future cures.
If you are interested in being a donor or research study participant, call today and schedule an appointment to learn more about our opportunities. Your participation could one day help treat cancer, sickle cell disease, and develop an effective vaccine for malaria. Make a difference today!